Health Care·Health Care Equipment·$158.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.75 | N/A | -1.29% |
management commentary, guidance changes, and full analysis available with Pro.
| -1.29% |
Tone: Defensive
Overall, management expressed concerns about market conditions impacting performance. They reiterated their commitment to navigating these challenges.
Management highlighted ongoing challenges in the market.
They emphasized a focus on cost management and operational efficiency.
Abbott Labs reported earnings that fell short of expectations, resulting in a slight decline in stock price. The lack of revenue data and guidance may leave investors cautious. Management's defensive tone suggests they are facing challenges ahead, which could impact future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
JOHNSON & JOHNSON
Oct 16, 2018